We are Sorry, This Page doesn't Exist
Earnings Results: Gilead stock rallies as it reports $1.9 billion in sales for its COVID-19 drug in Q4
Shares of Gilead Sciences Inc.'s stock gained 2.1% in after-hours trading on Thursday after the drug maker surprised investors with better-than-expected sales of its COVID-19 drug Veklury during the fourth quarter of 2020......»»
Gilead buys more Arcus Biosciences stock, at a price above the record close
Arcus Biosciences Inc. disclosed Monday that Gilead Sciences Inc. boosted its stake in the oncology-focused biopharmaceutical company, through the purchase of $220.35 million worth of stock. Arcus shares were still inactive in pr.....»»
June 26th Options Now Available For Gilead Sciences (GILD)
Stock Options Channel.....»»
Here’s Why Tao Value Loves Gilead Sciences (GILD) Stock
Tao Value recently released its Q1 2020 Investor Letter, a copy of which you can download here. The fund posted a return of -12.96% for t.....»»
Gilead stock downgraded over questions about remdesivir revenue
Shares of Gilead Sciences Inc. were down 5.9% in trading on Friday after at least three analysts downgraded the stock, citing a range of concerns. R.....»»
June 12th Options Now Available For Gilead Sciences (GILD)
Stock Options Channel.....»»
3 Big Stock Charts for Thursday: Gilead Sciences, Boeing, and Nio
InvestorPlace - Stock Market .....»»
US stock futures rise after solid tech earnings, Facebook up more than 10%
Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»
US stock futures rise after solid tech earnings
Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»
Here"s How Much Investing $100 In Gilead Sciences Stock Back In 2010 Would Be Worth Today
Investors who owned stocks in the 2010s generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return for the decade was 250.5%. But there’s no question some big-name stocks did much better than others along the way. read more.....»»
Dow jumps 650 points as stock-market gains intensify after Fauci says Gilead coronavirus trial drug is "quite good news"
U.S. stock benchmarks added to strong gains Wednesday afternoon after Dr. Anthony Fauci described data from a drug trial of Gilead Sciences' remdesivir showed "quite good news," in treating certain patients stricken with the illness from th.....»»
Why Gilead Stock Is Trading Higher Today
Gilead Sciences, Inc. (NASDAQ: GILD) .....»»
Futures jump after Gilead"s COVID-19 drug meets main goal
U.S. stock index futures jumped on Wednesday after Gilead Sciences said its experimental antiviral drug met the main goal of a trial testing it in COVID-19 patients......»»
Gilead"s stock halted, says remdesivir met primary endpoint in government study
Gilead Sciences Inc. said Wednesday morning that a government-run clinical trial evaluating its experimental drug remdesivir in certain COVID-19 patie.....»»
Don’t Let Negative Data Dissuade You from Gilead Sciences
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Late last week, a Financial Times report suggested that Gilead’s cor.....»»
Why Remdesivir Clinical Studies Will Lift Gilead Sciences
InvestorPlace - Stock Market News, Stock Advice & .....»»
Why Gilead Stock Is Trading Lower Today
Gilead Sciences, Inc. (NASDAQ: GILD) shares were trading lower Thursday after the Financial Times reported that the company ended a study on remdesivir in coronavirus in China due to low enrollment an read more.....»»
Gilead stock tumbles after Stat report on weak data in remdesivir trial in China
Shares of Gilead Sciences Inc. were down 5.3% in trading on Thursday after a Stat News report said a draft of the clinical trial results for remdesivir, an experimental drug being tested as a treatment for COVID-19, showed that the drug did not spe.....»»
BMO downgrades Gilead over concerns about commercial promise of remdesivir
Shares of Gilead Sciences Inc. gained 0.4% in trading on Monday after BMO Capital Markets downgraded the stock to market perform from outperform. Analysts there believe that despite [l: investor excitement about remdesivir, an experimental drug being .....»»
Gilead Analysts Tackle Early Results From Remdesivir Study In COVID-19, Morgan Stanley Says Stock Move Looks Overdone
Gilead Sciences, Inc. (NASDAQ: GILD) surged more than 16% after hours Thursday when STAT News reported promising preliminary results for a prospective COVID-19 thera Late.....»»